213 related articles for article (PubMed ID: 38113335)
41. The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1.
Ordureau A; Smith H; Windheim M; Peggie M; Carrick E; Morrice N; Cohen P
Biochem J; 2008 Jan; 409(1):43-52. PubMed ID: 17997719
[TBL] [Abstract][Full Text] [Related]
42. Deficiency in IRAK4 activity attenuates manifestations of murine Lupus.
Murphy M; Pattabiraman G; Manavalan TT; Medvedev AE
Eur J Immunol; 2017 May; 47(5):880-891. PubMed ID: 28295231
[TBL] [Abstract][Full Text] [Related]
43. Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex.
Jiang Z; Johnson HJ; Nie H; Qin J; Bird TA; Li X
J Biol Chem; 2003 Mar; 278(13):10952-6. PubMed ID: 12496252
[TBL] [Abstract][Full Text] [Related]
44. Brazilin selectively disrupts proximal IL-1 receptor signaling complex formation by targeting an IKK-upstream signaling components.
Jeon J; Lee JH; Park KA; Byun HS; Lee H; Lee Y; Zhang T; Kang K; Seok JH; Kwon HJ; Han MD; Kang SW; Hong JH; Hur GM
Biochem Pharmacol; 2014 Jun; 89(4):515-25. PubMed ID: 24735611
[TBL] [Abstract][Full Text] [Related]
45. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation.
Conze DB; Wu CJ; Thomas JA; Landstrom A; Ashwell JD
Mol Cell Biol; 2008 May; 28(10):3538-47. PubMed ID: 18347055
[TBL] [Abstract][Full Text] [Related]
46. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity.
Kim TW; Staschke K; Bulek K; Yao J; Peters K; Oh KH; Vandenburg Y; Xiao H; Qian W; Hamilton T; Min B; Sen G; Gilmour R; Li X
J Exp Med; 2007 May; 204(5):1025-36. PubMed ID: 17470642
[TBL] [Abstract][Full Text] [Related]
47. IRAK1: a critical signaling mediator of innate immunity.
Gottipati S; Rao NL; Fung-Leung WP
Cell Signal; 2008 Feb; 20(2):269-76. PubMed ID: 17890055
[TBL] [Abstract][Full Text] [Related]
48. IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma.
Cheng BY; Lau EY; Leung HW; Leung CO; Ho NP; Gurung S; Cheng LK; Lin CH; Lo RC; Ma S; Ng IO; Lee TK
Cancer Res; 2018 May; 78(9):2332-2342. PubMed ID: 29483095
[TBL] [Abstract][Full Text] [Related]
49. PKCδ-IRAK1 axis regulates oxidized LDL-induced IL-1β production in monocytes.
Tiwari RL; Singh V; Singh A; Rana M; Verma A; Kothari N; Kohli M; Bogra J; Dikshit M; Barthwal MK
J Lipid Res; 2014 Jul; 55(7):1226-44. PubMed ID: 24792928
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.
Burns K; Janssens S; Brissoni B; Olivos N; Beyaert R; Tschopp J
J Exp Med; 2003 Jan; 197(2):263-8. PubMed ID: 12538665
[TBL] [Abstract][Full Text] [Related]
51. Identification of optineurin as an interleukin-1 receptor-associated kinase 1-binding protein and its role in regulation of MyD88-dependent signaling.
Tanishima M; Takashima S; Honda A; Yasuda D; Tanikawa T; Ishii S; MaruYama T
J Biol Chem; 2017 Oct; 292(42):17250-17257. PubMed ID: 28882891
[TBL] [Abstract][Full Text] [Related]
52. RNF152 positively regulates TLR/IL-1R signaling by enhancing MyD88 oligomerization.
Xiong MG; Xu ZS; Li YH; Wang SY; Wang YY; Ran Y
EMBO Rep; 2020 Mar; 21(3):e48860. PubMed ID: 31930677
[TBL] [Abstract][Full Text] [Related]
53. IRAK4 kinase activity is not required for induction of endotoxin tolerance but contributes to TLR2-mediated tolerance.
Xiong Y; Pennini M; Vogel SN; Medvedev AE
J Leukoc Biol; 2013 Aug; 94(2):291-300. PubMed ID: 23695305
[TBL] [Abstract][Full Text] [Related]
54. IRAK4 kinase activity is redundant for interleukin-1 (IL-1) receptor-associated kinase phosphorylation and IL-1 responsiveness.
Qin J; Jiang Z; Qian Y; Casanova JL; Li X
J Biol Chem; 2004 Jun; 279(25):26748-53. PubMed ID: 15084582
[TBL] [Abstract][Full Text] [Related]
55. IRAK Inhibitor Protects the Intestinal Tract of Necrotizing Enterocolitis by Inhibiting the Toll-Like Receptor (TLR) Inflammatory Signaling Pathway in Rats.
Hou Y; Lu X; Zhang Y
Med Sci Monit; 2018 May; 24():3366-3373. PubMed ID: 29784900
[TBL] [Abstract][Full Text] [Related]
56. Modulation of Toll-interleukin 1 receptor mediated signaling.
Li X; Qin J
J Mol Med (Berl); 2005 Apr; 83(4):258-66. PubMed ID: 15662540
[TBL] [Abstract][Full Text] [Related]
57. Cloning and functional characterization of IRAK4 in large yellow croaker (Larimichthys crocea) that associates with MyD88 but impairs NF-κB activation.
Zou PF; Huang XN; Yao CL; Sun QX; Li Y; Zhu Q; Yu ZX; Fan ZJ
Fish Shellfish Immunol; 2017 Apr; 63():452-464. PubMed ID: 27989863
[TBL] [Abstract][Full Text] [Related]
58. Pellino proteins: novel players in TLR and IL-1R signalling.
Schauvliege R; Janssens S; Beyaert R
J Cell Mol Med; 2007; 11(3):453-61. PubMed ID: 17635639
[TBL] [Abstract][Full Text] [Related]
59. FADD negatively regulates lipopolysaccharide signaling by impairing interleukin-1 receptor-associated kinase 1-MyD88 interaction.
Zhande R; Dauphinee SM; Thomas JA; Yamamoto M; Akira S; Karsan A
Mol Cell Biol; 2007 Nov; 27(21):7394-404. PubMed ID: 17785432
[TBL] [Abstract][Full Text] [Related]
60. Pharmacological inhibition of IRAK1 and IRAK4 prevents endothelial inflammation and atherosclerosis in ApoE
Wu X; Xu M; Liu Z; Zhang Z; Liu Y; Luo S; Zheng X; Little PJ; Xu S; Weng J
Pharmacol Res; 2022 Jan; 175():106043. PubMed ID: 34954030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
